President Donald Trump named former Eli Lilly executive Alex Azar to lead the Department of Health and Human Services after agency’s past chief resigned amid blowback over his taxpayer-funded private jet travel.
“Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices!” Trump tweeted Monday.
If confirmed, Azar will take over the administration’s management of the Affordable Care Act. Trump and congressional Republicans have called to repeal the health law, and the administration has taken steps to destabilize it, such as cutting funding for some programs and refusing to pay subsidies to health insurers. He’ll also be a key figure on drug costs.
Trump has been highly critical of the drug industry, saying that pharmaceutical companies are “getting away with murder” and threatening to use the federal government’s buying power to bring down prices.
(c) 2017, Bloomberg · Anna Edney, Jared S. Hopkins
{Matzav.com}
Aha. So then Trump goes and hires someone from the corrupt pharmaceutical companies. Sure, that makes sense. This will only fuel those anti vaxers.
It’s time to do a claw-back on the “colchicine” drug company. They took a very popular drug that was selling for under 10 cents and bumped it up to $5.00 @ (a whopping 5400%). All under the co-operating noses of the FDA.
Let’s do a roll back and a clawback.